N-[(3E)-3-ethenylhexa-3,5-dien-2-yl]-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyridin-2-amine
C19H24N4 — CID 143813419
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3E)-3-ethenylhexa-3,5-dien-2-yl]-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyridin-2-amine
N-[(3E)-3-ethenylhexa-3,5-dien-2-yl]-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyridin-2-amine (PubChem CID 143813419) has the molecular formula C19H24N4 and a molecular weight of 308.43 g/mol. Its IUPAC name is N-[(3E)-3-ethenylhexa-3,5-dien-2-yl]-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyridin-2-amine.
Molecular Properties
| Compound Name | N-[(3E)-3-ethenylhexa-3,5-dien-2-yl]-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyridin-2-amine |
|---|---|
| PubChem CID | 143813419 |
| Molecular Formula | C19H24N4 |
| Molecular Weight | 308.43 g/mol |
| Exact Mass | 308.20 |
| IUPAC Name | N-[(3E)-3-ethenylhexa-3,5-dien-2-yl]-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyridin-2-amine |
| SMILES | C=C/C=C(\C=C)C(C)Nc1cc(-c2cn[nH]c2C(C)C)ccn1 |
| InChI | InChI=1S/C19H24N4/c1-6-8-15(7-2)14(5)22-18-11-16(9-10-20-18)17-12-21-23-19(17)13(3)4/h6-14H,1-2H2,3-5H3,(H,20,22)(H,21,23)/b15-8+ |
| InChIKey | RAPAXFAHOXLAGL-OVCLIPMQSA-N |
| XLogP | 4.69 |
| TPSA | 53.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 308.43 |
| LogP ≤ 5 | 4.69 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143813419 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.